VibroSense Dynamics (VSD) investor relations material

Executive summary

• Net sales for Q6 (Oct–Dec 2025) were SEK 422,481, down 8.9% year-over-year, mainly from sales and rentals of foot and hand instruments.

• Result after financial items for Q6 was SEK -1,574,040, impacted by inventory write-downs and reclassification of patent costs.

• For the 18-month period (Jul 2024–Dec 2025), net sales reached SEK 3,130,551, up from SEK 2,131,974 in the previous 12-month period.

• International expansion accelerated, with new research collaborations and increased sales activity in Europe and Asia.

Financial highlights

• Q6 net sales: SEK 422,481 (SEK 463,818 last year); 18-month net sales: SEK 3,130,551 (SEK 2,131,974 prior 12 months).

• Q6 result after financial items: SEK -1,574,040 (SEK -969,557 last year); 18-month result: SEK -7,532,674 (SEK -7,668,669 prior 12 months).

• Earnings per share for Q6: SEK -0.05 (SEK -0.04); for 18 months: SEK -0.24 (SEK -0.29).

• Cash and cash equivalents at Dec 31, 2025: SEK 6,745,543 (SEK 13,103,483 last year).

• Solid equity ratio at 83.6% (84.4% last year).

Outlook and guidance

• Entering 2026 with a strong financial position and confidence in international growth opportunities.

• Short-term revenue impacted by delayed China launch, but long-term growth expected from clinical collaborations and new distributor agreements.

• Board assesses sufficient liquidity for operations throughout 2026.